949-257-5108

info@radnumbers.com


FREE Consultation
  • In terms of greater adherence to the existent clinical guidelines based

  • 25 May 2021 by 0 Comments

In terms of greater adherence to the existent clinical guidelines based on evidence as well as cost-effectiveness [16,18].The trend toward increasing numbers of prescriptions involving ARBs, as summarized in Table 4, is also worthy of some attention. Indeed, the multiple logistic regression analysis indicated that the calendar year and the size of the clinical facility were actually the major determinants, although we deliberately restricted our subjects to those newly-diagnosed with uncomplicated hypertension and mono-therapies to prevent systematic differences in patients’ characteristics. We have also found that primary care clinics prescribed diuretics more frequently than the larger medical facilities. We suspect that differences in cost consciousness may be an important contributor to this particular PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/3986429 phenomenon, since the current reimbursement policy within the NHI program seems less restrictive on medical centers and regional hospitals, as compared with primary local clinics. Another possibility is that physicians in large medical facility are more frequently exposed to new drugs and tending to readily accept the latest, or most up-to-date, medications [33]. In fact, the number of ARBs on the market increased from 2 to 9 during the period of 1998?004. Some studies suggest that promotional activities of pharmaceutical industry have a major impact on physicians’ prescribing patterns [34,35]. More evidence needs to be collected to corroborate these beliefs.Page 7 of(page number not for citation purposes)Page 8 of PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/1425957 11 Total No. of prescriptionsb Others No. 12.78# 7.40 44 738 50 059 6.12# 12.77 40 357 54 440 985 967 5.89# 6.53# 10.35# 12.40 9.94 16 721 14 809 18 258 44 997 94http://www.biomedcentral.com/1472-6963/8/Table 3: Distribution of mono-therapy antihypertensive drug prescriptions for newly-diagnosed uncomplicated hypertension patientsaClass of drugb Variables Diuretics No. Patient gender Male Female Patient age (years) <55 55 Type of clinical facilityd Medical center Regional hospital Local hospital 1 067 1 026 1 363 4 367 7 823 6.38# 6.93# 7.47# 9.71 8.25 4 474 4 144 4 171 13 043 25 835 26.76# 27.98 22.84# 28.99 27.25 5 841 5 690 8 186 11 991 31 711 34.93# 38.42# 44.84# 26.65 33.45 2 255 1 710 1 728 8 927 14 623 13.49# 11.55# 9.46# 19.84 15.43 2 099 1 272 920 1 089 5 383 12.55# 8.59# 5.04# 2.42 5.68 2 366 5 457 5.86# 10.02 13 627 12 208 33.77# 22.42 12 083 19 628 29.94# 36.05 7 134 7 489 17.68# 13.76 2 677 2 706 6.63# 4.97 2 470 6 952 2 974 4 849 6.65# 9.69 11 602 14 233 25.93# 28.43 14 AT-56 881 16 830 33.26 33.62 7 004 7 619 15.66 15.22 2 561 2 822 5.72 5.64 5 716 3 706 Beta-blockers No. No. CCBsc ACE inhibitorsc No. No. ARBsc1 890 5 580 9BMC Health Services Research 2008, 8:Primary care clinic Total Nos.Notes: a Total sample number of prescriptions = 94 797. b No. refers to the number of prescriptions for each class of drug; refers to the percentage of the total prescriptions for the six classes of drugs. As a result of missing data, the sum of the total number of prescriptions over the four types of clinical facilities is smaller than the overall number of prescriptions. c CCBs = calcium channel blockers; ACE = angiotensin-converting enzyme; ARBs = angiotensin receptor blockers. d Pairwise group comparisons are performed taking primary care clinics as the reference. # Significant p-value with the Bonferroni-adjusted -level, p < 0.(page number not for citation purposes)BMC Health Services Research 2008, 8:http://www.b.

Leave a Reply

Your email address will not be published.